Luís Lopes Madureira Silva Miguel
AuthID: R-000-9J6
11
TITLE: Clinical and economic consequences of using dabigatran or rivaroxaban in patients with non-valvular atrial fibrillation
AUTHORS: Luis Silva Miguel; Jorge Ferreira;
PUBLISHED: 2016, SOURCE: REVISTA PORTUGUESA DE CARDIOLOGIA, VOLUME: 35, ISSUE: 3
AUTHORS: Luis Silva Miguel; Jorge Ferreira;
PUBLISHED: 2016, SOURCE: REVISTA PORTUGUESA DE CARDIOLOGIA, VOLUME: 35, ISSUE: 3
INDEXED IN: WOS
12
TITLE: Comment on "Cost-effectiveness of rivaroxaban for stroke prevention in atrial fibrillation in the Portuguese setting''
AUTHORS: Luis Silva Miguel;
PUBLISHED: 2015, SOURCE: REVISTA PORTUGUESA DE CARDIOLOGIA, VOLUME: 34, ISSUE: 11
AUTHORS: Luis Silva Miguel;
PUBLISHED: 2015, SOURCE: REVISTA PORTUGUESA DE CARDIOLOGIA, VOLUME: 34, ISSUE: 11
INDEXED IN: WOS
13
TITLE: COST-UTILITY ANALYSIS OF DELAYED-RELEASE DIMETHYL FUMERATE FOR THE TREATMENT OF RELAPSING-REMITTING MULTIPLE SCLEROSIS IN PORTUGAL Full Text
AUTHORS: Silva Miguel, LS; de Sa, J; Pinheiro, B; Acosta, C;
PUBLISHED: 2015, SOURCE: VALUE IN HEALTH, VOLUME: 18, ISSUE: 7
AUTHORS: Silva Miguel, LS; de Sa, J; Pinheiro, B; Acosta, C;
PUBLISHED: 2015, SOURCE: VALUE IN HEALTH, VOLUME: 18, ISSUE: 7
INDEXED IN: WOS
14
TITLE: DELAYED ENHANCEMENT CARDIAC MAGNETIC RESONANCE TO REFINE PATIENT SELECTION FOR IMPLANTABLE CARDIOVERTER DEFIBRILLATOR THERAPY IN PRIMARY PREVENTION - AN EXPLORATORY COST-EFECTIVENESS ANALYSIS Full Text
AUTHORS: Silva Miguel, LS; Ferreira, AM;
PUBLISHED: 2015, SOURCE: VALUE IN HEALTH, VOLUME: 18, ISSUE: 7
AUTHORS: Silva Miguel, LS; Ferreira, AM;
PUBLISHED: 2015, SOURCE: VALUE IN HEALTH, VOLUME: 18, ISSUE: 7
INDEXED IN: WOS
15
TITLE: RISK FACTORS FOR DEVELOPING DIABETES AS A DETERMINANT OF THE COST-EFECTIVENESS OF USING CORONARY CALCIUM SCORE TO GUIDE PRIMARY PREVENTION WITH STATINS Full Text
AUTHORS: Silva Miguel, LS; Ferreira, AM;
PUBLISHED: 2015, SOURCE: VALUE IN HEALTH, VOLUME: 18, ISSUE: 7
AUTHORS: Silva Miguel, LS; Ferreira, AM;
PUBLISHED: 2015, SOURCE: VALUE IN HEALTH, VOLUME: 18, ISSUE: 7
INDEXED IN: WOS
16
TITLE: COST-EFFECTIVENESS ANALYSIS OF OBINUTUZUMAB FOR PREVIOUSLY UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) IN PORTUGUESE PATIENTS THAT ARE UNSUITABLE FOR FULL-DOSE FLUDARABINE BASED THERAPY Full Text
AUTHORS: Paquete, A; Miguel, LS; Pereira, C; Pinto, CG;
PUBLISHED: 2015, SOURCE: VALUE IN HEALTH, VOLUME: 18, ISSUE: 7
AUTHORS: Paquete, A; Miguel, LS; Pereira, C; Pinto, CG;
PUBLISHED: 2015, SOURCE: VALUE IN HEALTH, VOLUME: 18, ISSUE: 7
INDEXED IN: WOS
17
TITLE: ECONOMIC EVALUATION OF TIOTROPIUM FOR SEVERE PERSISTENT ASTHMA IN PORTUGAL Full Text
AUTHORS: Silva Miguel, LS; Manacas, M; Pinheiro, B;
PUBLISHED: 2015, SOURCE: VALUE IN HEALTH, VOLUME: 18, ISSUE: 7
AUTHORS: Silva Miguel, LS; Manacas, M; Pinheiro, B;
PUBLISHED: 2015, SOURCE: VALUE IN HEALTH, VOLUME: 18, ISSUE: 7
INDEXED IN: WOS
18
TITLE: ECONOMIC EVALUATION OF AXITINIB FOR SECOND LINE TREATMENT IN ADULT PATIENTS WITH ADVANCED RENAL CELL CARCINOMA - THE PORTUGUESE CASE Full Text
AUTHORS: Miguel, LS; Luz, R;
PUBLISHED: 2014, SOURCE: VALUE IN HEALTH, VOLUME: 17, ISSUE: 7
AUTHORS: Miguel, LS; Luz, R;
PUBLISHED: 2014, SOURCE: VALUE IN HEALTH, VOLUME: 17, ISSUE: 7
INDEXED IN: WOS
19
TITLE: Avaliação económica do dabigatrano na prevenção de acidentes vasculares cerebrais isquémicos em doentes com fibrilhação auricular não valvular
AUTHORS: Luís Silva Miguel; Evangelista Rocha; Jorge Ferreira;
PUBLISHED: 2013, SOURCE: Revista Portuguesa de Cardiologia, VOLUME: 32, ISSUE: 7-8
AUTHORS: Luís Silva Miguel; Evangelista Rocha; Jorge Ferreira;
PUBLISHED: 2013, SOURCE: Revista Portuguesa de Cardiologia, VOLUME: 32, ISSUE: 7-8
20
TITLE: COST-UTILITY ANALYSIS OF CORONARY ARTERY CALCIUM SCORE TO GUIDE STATIN THERAPY IN PATIENTS WITH ELEVATED C-REACTIVE PROTEIN AND LOW LDL CHOLESTEROL LEVELS Full Text
AUTHORS: Silva Miguel, LS; Ferreira, AM;
PUBLISHED: 2013, SOURCE: VALUE IN HEALTH, VOLUME: 16, ISSUE: 7
AUTHORS: Silva Miguel, LS; Ferreira, AM;
PUBLISHED: 2013, SOURCE: VALUE IN HEALTH, VOLUME: 16, ISSUE: 7
INDEXED IN: WOS